Correlation Between CytomX Therapeutics and Scisparc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Scisparc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Scisparc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Scisparc, you can compare the effects of market volatilities on CytomX Therapeutics and Scisparc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Scisparc. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Scisparc.

Diversification Opportunities for CytomX Therapeutics and Scisparc

0.43
  Correlation Coefficient

Very weak diversification

The 3 months correlation between CytomX and Scisparc is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Scisparc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scisparc and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Scisparc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scisparc has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Scisparc go up and down completely randomly.

Pair Corralation between CytomX Therapeutics and Scisparc

Given the investment horizon of 90 days CytomX Therapeutics is expected to under-perform the Scisparc. But the stock apears to be less risky and, when comparing its historical volatility, CytomX Therapeutics is 1.6 times less risky than Scisparc. The stock trades about -0.04 of its potential returns per unit of risk. The Scisparc is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  23.00  in Scisparc on August 28, 2024 and sell it today you would earn a total of  1.00  from holding Scisparc or generate 4.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

CytomX Therapeutics  vs.  Scisparc

 Performance 
       Timeline  
CytomX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CytomX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Scisparc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scisparc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

CytomX Therapeutics and Scisparc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CytomX Therapeutics and Scisparc

The main advantage of trading using opposite CytomX Therapeutics and Scisparc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Scisparc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scisparc will offset losses from the drop in Scisparc's long position.
The idea behind CytomX Therapeutics and Scisparc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk